Delivery Order SPE2DB22D3016-SPE2DB25FANE2
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,494.33 firm fixed-price delivery order is for the supply of RAMIPRIL 2.5 MG CAPSULE 500S, a cardiovascular medication, with a period of performance through April 17, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,727.69, is for the delivery of Ramipril 10 mg capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of July 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $2,879.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This delivery order is for 4,563,273,583 units of the medication Ramipril 10 mg capsules, which are used to treat...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 10mg capsules of the medication Ramipril. The $6,992.95 Firm Fixed Price contract has a completion date of September 25, 2024. AmerisourceBergen is delivering these medications to support military treatment facilities and other federal healthcare providers through this delivery order. No set-aside was used for this award....
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FS77A, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,899.68 firm-fixed-price delivery order is for the supply of 4,563,789,849 units of the 10 mg Ramipril capsule medication. The award has an ultimate completion date of February 28, 2024 and was made on February 27, 2024. This contract is not designated as a set-aside....
This federal contract award is for the delivery of Ramipril 10 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $4,564.62, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Ramipril 2.5 mg capsules to the Defense Logistics Agency (DLA). The $1,131.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 19, 2022. The contract has a completion date of September 20, 2022 and was not set aside for any specific business category. Amerisourcebergen is a major pharmaceutical distributor that holds two significant Indefinite Delivery Contracts (IDCs) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ramipril 10 mg capsules. The contract, which has a ceiling value of $2,650.03, is a firm fixed-price delivery order with an ultimate completion date of August 26, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB24FA2R6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price type, valued at $1,674.69, for the procurement of RAMIPRIL 5 MG CAPSULE 100S. The contract has an ultimate completion date of February 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award, with a ceiling value of $1,604.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,086,379 capsules of the pharmaceutical drug Ramipril 2.5 mg. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...